
Current Price | $7.57 | Mkt Cap | $621.4M |
---|---|---|---|
Open | $7.15 | P/E Ratio | -12.68 |
Prev. Close | $7.57 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $7.01 - $7.62 | Volume | 1,070,483 |
52-Wk Range | $4.90 - $12.11 | Avg. Daily Vol. | 1,008,108 |
Current Price | $7.57 | Mkt Cap | $621.4M |
---|---|---|---|
Open | $7.15 | P/E Ratio | -12.68 |
Prev. Close | $7.57 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $7.01 - $7.62 | Volume | 1,070,483 |
52-Wk Range | $4.90 - $12.11 | Avg. Daily Vol. | 1,008,108 |
The best Bull and Bear pitches based on recency and number of recommendations.
Speculative Pick (2% max allocation would be wise); Sharing my number one stock pick once again; Where many others have failed and gone home, Anavex continues to march towards the first effective treatment for dementia in history; Stock recently fell… More
Been about 4 years since Anavex raised a heap of money after posting "successful" midstage data. How's that phase 3 Alzheimer's study with 2-73 coming along?
Read the most recent pitches from players about AVXL.
Recs
Speculative Pick (2% max allocation would be wise); Sharing my number one stock pick once again; Where many others have failed and gone home, Anavex continues to march towards the first effective treatment for dementia in history; Stock recently fell after they reported positive Phase I results for another candidate in their pipeline (3-71); Investors are too quick to fold their hands; They forget that she is close to completing Phase III testing for her flagship candidate 2-73; 100% of trial study patients have voluntarily signed up for continued treatment under extended long term study protocols since Phase I; Study goals exceed required FDA data points; They’ve also received positive feedback from preliminary FDA reviews with zero change recommendations offered; I predict full FDA approval before year's end; Stock likely to move long before then regardless of what the general market is doing
Recs
Shrinking deficit and improving technicals.
Recs
Been about 4 years since Anavex raised a heap of money after posting "successful" midstage data. How's that phase 3 Alzheimer's study with 2-73 coming along?
Find the members with the highest scoring picks in AVXL.
DorminABC (99.73) Score: +309.54
The Score Leader is the player with the highest score across all their picks in AVXL.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
DorminABC | 99.73 | 3/17/2011 |
![]() |
NS | $15.28 | -50.79% | +258.76% | +309.54 | 0 Comment | |
Under5 | 55.47 |
|
![]() |
5Y | $2.13 | +253.05% | +69.60% | +183.45 | 0 Comment | |
whatisthepoint | 90.89 | 10/12/2015 |
![]() |
5Y | $9.52 | -21.01% | +128.37% | +149.38 | 0 Comment | |
Theige | 28.85 | 10/12/2015 |
![]() |
5Y | $8.30 | -9.40% | +127.93% | +137.33 | 0 Comment | |
MMCapitalMgmt | 95.90 | 10/23/2015 |
![]() |
5Y | $7.18 | +4.74% | +121.43% | +116.69 | 0 Comment | |
FSaucy | 93.66 | 10/6/2015 |
![]() |
NS | $6.12 | +22.88% | +132.53% | +109.65 | 0 Comment | |
jed71 | 45.55 |
|
![]() |
5Y | $5.20 | +44.62% | +136.67% | +92.06 | 0 Comment | |
TinyCapsWatch | 98.58 | 7/5/2016 |
![]() |
5Y | $5.80 | +29.66% | +119.72% | +90.06 | 0 Comment | |
fps32 | 68.88 | 9/3/2015 |
![]() |
5Y | $4.84 | +55.37% | +133.92% | +78.55 | 0 Comment | |
zzlangerhans | 98.77 | 2/18/2016 |
![]() |
1Y | $4.27 | +76.11% | +139.08% | +62.96 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.